Imuracetam
- Level
- Commodity
- Parent
- 51143000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51143001This classification denotes a neuroprotective agent with the molecular formula C11H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 972FNV35ZM, chemically known as 1,3-bis((2-oxo-1-pyrrolidinyl)methyl)harnstoff but generally known as imuracetam, which bears US NIH Compound Identifier 163319. European Medicines Agency schedules Imuracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08161MIG. The term IMURACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). IMURACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imuracetam under HS 29337900 and SITC 51561. As of Q4 2014, IMURACETAM remains the US FDA Preferred Term for this commodity. Imuracetam bears US NLM identifiers UMLS ID C1881153 and NCI Concept Code C65904. SMILES: C1CC(=O)N(C1)CNC(=O)NCN2CCCC2=O.
Same parent
Under 51143000 · 22Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.